Showing 2 posts of 2 posts found.
The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …
NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma
AstraZeneca’s Trixeo approved in EU for asthma
Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis
Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial
ESTEVE CDMO adds $17.5m to Illinois expansion